Reunion Neuroscience Alpha and Beta Analysis

REUNDelisted Stock  USD 1.12  0.01  0.90%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Reunion Neuroscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Reunion Neuroscience over a specified time horizon. Remember, high Reunion Neuroscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Reunion Neuroscience's market risk premium analysis include:
Beta
(1.24)
Alpha
0.97
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Reunion Neuroscience alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Reunion Neuroscience did 0.97  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Reunion Neuroscience stock's relative risk over its benchmark. Reunion Neuroscience has a beta of 1.24  . As returns on the market increase, returns on owning Reunion Neuroscience are expected to decrease by larger amounts. On the other hand, during market turmoil, Reunion Neuroscience is expected to outperform it. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Reunion Neuroscience Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Reunion Neuroscience market risk premium is the additional return an investor will receive from holding Reunion Neuroscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Reunion Neuroscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Reunion Neuroscience's performance over market.
α0.97   β-1.24

Reunion Neuroscience Fundamentals Vs Peers

Comparing Reunion Neuroscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Reunion Neuroscience's direct or indirect competition across all of the common fundamentals between Reunion Neuroscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Reunion Neuroscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Reunion Neuroscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Reunion Neuroscience by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Reunion Neuroscience to competition
FundamentalsReunion NeurosciencePeer Average
Return On Equity-0.86-0.31
Return On Asset-0.27-0.14
Current Valuation(13.96 M)16.62 B
Shares Outstanding11.72 M571.82 M
Shares Owned By Insiders34.39 %10.09 %
Shares Owned By Institutions50.65 %39.21 %
Number Of Shares Shorted114.9 K4.71 M

Reunion Neuroscience Opportunities

Reunion Neuroscience Return and Market Media

The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Reunion Neuroscience Announces 13.1M Take-Private Transaction With Biotech Investment Firm
06/01/2023
2
Whats Going On With Reunion Neuroscience Stock Today
06/02/2023
3
U.S. East Coast blanketed in eerie veil of smoke from Canada fires - Marketscreener.com
06/07/2023
4
Citing Food Allergy Incidents, Family Pulls Kids Out of VA Schools - Allergic Living
06/16/2023
5
The Class of 2023 Leaves With a Song In Their Heart - Scarsdale10583.com
06/23/2023
6
Stella acquires Field Trips U.S. assets to enhance its psychedelic therapy offerings - Mugglehead
06/28/2023
7
Field Trip Health Trading Down 2.3
07/05/2023
8
Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement
07/14/2023

About Reunion Neuroscience Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Reunion or other delisted stocks. Alpha measures the amount that position in Reunion Neuroscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Reunion Neuroscience Upcoming Company Events

As portrayed in its financial statements, the presentation of Reunion Neuroscience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Reunion Neuroscience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Reunion Neuroscience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Reunion Neuroscience. Please utilize our Beneish M Score to check the likelihood of Reunion Neuroscience's management manipulating its earnings.
27th of September 2023
Upcoming Quarterly Report
View
13th of November 2023
Next Financial Report
View
30th of June 2023
Next Fiscal Quarter End
View
26th of June 2024
Next Fiscal Year End
View
31st of March 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

Build Portfolio with Reunion Neuroscience

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Reunion Stock

If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format